An observational study in Brain Function and Cerebral Palsy, sponsored by IRCCS Fondazione Stella Maris. Recruiting at 2 sites in Italy. Open to participants aged 11 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-13.
Sponsored by IRCCS Fondazione Stella Maris · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Cerebral Palsy by IRCCS Fondazione Stella Maris — 10 open to participants now, 10 under way, none of them phase 3. Cerebral Palsy · IRCCS Fondazione Stella Maris.
Among the 16 studies in Cerebral Palsy by IRCCS Fondazione Stella Maris, this one is one of 3 that started in 2024, is one of 8 observational ones, and was the 12th registered.
1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.
Browse Cerebral Palsy studies →10 of the 16 studies in Cerebral Palsy by IRCCS Fondazione Stella Maris are open now, in 2 countries. Recruiting first, the newest first:
IRCCS Fondazione Stella Maris · Sites in Italy
Ages 7–25 · Healthy volunteers
IRCCS Fondazione Stella Maris · Sites in Italy
Ages 4–18
IRCCS Fondazione Stella Maris · Sites in Italy
Ages 2 mo–5 mo · Healthy volunteers
IRCCS Fondazione Stella Maris · Sites in Italy
Ages 6–21 · Healthy volunteers
IRCCS Fondazione Stella Maris · Sites in Italy
Ages 5–15 · Healthy volunteers
By country, each count listing its studies:
Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.
This study: 11 Years to 40 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 3 started in 2024.
This study's planned enrollment of 40 is below the median of 63 across 474 observational studies indexed under Cerebral Palsy.
Median enrollment 57 across the 8 interventional studies, 80 across the 8 observational. Of the 4 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
IRCCS Fondazione Stella Maris is the lead sponsor of 46 studies on the registry; 27 are open to participants now.
4 of the studies in Cerebral Palsy by IRCCS Fondazione Stella Maris that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07793032IRCCS Fondazione Stella MarisExperimental Validation of the Virtual Eggs Test (VET) in the Pediatric Population | 2026-11-30 |
| NCT06288971IRCCS Fondazione Stella MarisPersonalized Innovative Intervention Pathways to Promote EF in Children With CP | 2027-01-31 |
| NCT07369193IRCCS Fondazione Stella MarisImmersive AOT: Multisensory Stimulation and Neurophysiological Correlates in Children With Cerebral Palsy and Typical Development - A Pilot Study | 2027-06 |
| NCT07369167IRCCS Fondazione Stella MarisNeural Correlates of Goal-directed Action Observation and Execution in Children With Unilateral Cerebral Palsy | 2027-07 |
Add all 4 to your calendar (.ics) → With an account.
Among the 16 studies in Cerebral Palsy by IRCCS Fondazione Stella Maris, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The goal of this study is to explore the anatomical-functional characteristics of the AON circuit (with particular interest for subcortical areas and the cerebellum), and the cortico-subcortical connectivity of the nodes of the AON circuit, using an ultra-high field (7T), high spatial resolution Magnetic Resonance Imaging protocol.
The main questions it aims to answer are:
Participants will perform a 7 Tesla MRI scan, with a functional and anatomical dedicated protocol and will have a comprehensive clinical assessment before the MRI exam.
In healthy humans, brain functional representation of actions, either executed or observed, relies on the human action observation network (AON). Several studies demonstrated that AON activation is crucial for action understanding and for subserving imitation by observation of new motor skills. The demonstration of the activation of this circuit in patients with motor disorders have opened the way to new rehabilitation protocols based on the observation of meaningful actions followed by their execution (Observation to Imitate), often referred as Action Observation Therapy (AOT). In the last decade, AOT was widely used in adult stroke patients as well as in children with cerebral palsy (CP). Overall, these studies demonstrate a significant motor improvement after therapy, that is maintained at follow-up.
Functional Magnetic Resonance Imaging (fMRI) studies on the effects of AOT found a positive correlation between the functional improvements of manual abilities of these patients and the enlargement of movement-related brain regions, suggesting that AOT can promote the activation of mechanisms of brain plasticity and functional reorganization of the cortical areas responsible for movements. Recently, fMRI studies have demonstrated that also other brain regions, such as the cerebellum, the thalamus and the basal ganglia, belong to the AON.
Despite numerous studies on AON, the fine-grained details of this complex network, especially at subcortical level, and the reciprocal interactions between different brain regions are largely unknown. Moreover, no studies are available at submillimeter level concerning the involvement of subcortical structures. Compared with lower magnetic field systems, Ultra-High Field Magnetic Resonance (UHF-MR) permits a remarkable gain in terms of signal to noise ratio (SNR). This significant increase in SNR produces a great improvement of all imaging parameters, and can be exploited increasing spatial and/or temporal resolution. Moreover, at 7T, we assist also to an empowered sensitivity of the signal to modifications of the composition of tissue that can be translated in new or improved contrasts, such as susceptibility-weighted imaging.
fMRI technique is an advanced MR method that benefits from the use of UHF thanks to the positive combination of increased SNR and increased sensitivity to the effect generating the contrast (BOLD effect).
It has been demonstrated that an increase in the spatial resolution of UHF fMRI allows to describe the functional architecture of the cerebral cortex at mesoscopic (sub-millimeter) scale, hence revealing cortical columns-laminar fMRI profiles, and to segment subcortical structures, to explore their functional selectivity to external stimuli and topographic organization, and to study the cortex. Moreover, the increase in the sensitivity of fMRI at 7T allows to obtain statistically significant functional maps of brain activation not only in groups of subjects but also in individual subjects and individual events, opening new perspectives in the use of fMRI for clinical purposes.
The present study aims to use 7T fMRI to understand the mechanisms of the functional organization of the AON circuit, and in particular the relationship between the cerebral cortex and other structures such as the subcortical nuclei and the cerebellum, and to explore how this organization changes in the presence of lesions acquired at an early age, such as in patients with brain lesions that arose in the pre- or perinatal period, like Cerebral Palsy (CP).
We intend to enroll 28 healthy human subjects and 12 adolescents or young adults with CP. All participants will perform a 7 Tesla MRI scan, with a functional and anatomical dedicated protocol and CP patients will have a comprehensive clinical assessment before the MRI exam.
The MR protocol includes 3D MR sequences with very high spatial resolution. In particular, T1-weighted sequences with isotropic voxel size of 0.8mm is used in order to highlight and segment small substructures, but at the same time evaluating the compliance of subjects, especially of patients, in maintaining the position for long acquisition, without introducing motion artifacts. Analogously, 3D FLAIR sequences are acquired for a detailed study of lesions in CP patients.
fMRI acquisitions in humans are carried out by using Gradient-Echo Echo-Planar Imaging (GRE-EPI) sequences with spatial resolutions depending on the target of each functional series and by using imaging acceleration techniques as SENSE and multi-band approaches. For the study of functional connectivity and the whole AON circuit, comprehensive of the cerebellum, we will privilege whole brain coverage and relatively short temporal resolution (1-1.5 seconds), with a spatial resolution of 1.5mm isotropic voxel. On the other hand, for small substructures and laminar column studies, we will optimize an fMRI acquisition with isotropic voxel size of 0.7-0.9mm.
As functional task we use paradigms already described in previous studies and adapted for the 7T scanner.
Visual stimuli are presented in binocular vision by means of Liquid Cristal Display (LCD) goggles (VisuaStim-SVGA-Resonance Technology, USA). Participants observe short video-clips (lasting 4 s each), showing unimanual or bimanual actions performed by an actor, from a subjective perspective. The observed actions consist in grasping and using different tools (e.g., hammering, using a screwdriver, opening a jar etc.) or, as control condition, observation of the static initial frame of each clip. The objects are of different colors in order to avoid visual adaptation. The visual characteristics of each video are balanced between the experimental conditions to control the effects of brightness, contrast, sharpness and amount of visual information. During the rest period, in the absence of experimental stimuli, the participant have to fixate a white cross on a black background. During the entire fMRI acquisition, subject's performance are visually checked by the experimenter and kinematic parameters are recorded by using MR-compatible cameras.
primary care clinic for CP; community sample for HC.
For CP patients
Inclusion Criteria:
Exclusion Criteria:
For Healthy Controls
Inclusion Criteria:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Subject without any known neurological and psychiatric pathologies
Other: 7T MR exam
Patients with pre-, peri- or post-natal brain injury, as documented in a previous brain MRI examination
Other: 7T MR exam · Other: clinical assessment
a 7 Tesla MRI scan, with a functional and anatomical dedicated protocol
A comprehensive clinical assessment before the MRI exam.
7T activation maps of the AON
volume (in cubic millimeters), coordinates (in millimeters), and percentage of signal change of the cortical, subcortical and cerebellar areas elicited by the observation of goal-directed actions
Time frame: Day 0
7T connectivity maps of the AON
correlation between each pair of the cortical, subcortical and cerebellar areas elicited by the observation of goal-directed actions
Time frame: Day 0
reproducibility
percentage of healthy subjects in which it is possible to identify the AON circuit
Time frame: Day 0
clinical correlation
correlation between characteristics of activations (described as primary outcomes) and clinical assessment
Time frame: Day 0
Not enrolling at this site.
Plan to share: Undecided — To be decided, verifying the compliance with European General Data Protection Regulation (GDPR) law
No publications or documents are linked to this record.
Started Dec 2024 (actual). Primary completion is estimated for Aug 2025, 8 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
IRCCS Fondazione Stella Maris